Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (武汉明德生物科技股份有限公司) (China)

Wuhan Easy Diagnosis Biomedicine Co., Ltd. is a healthcare company headquartered in Wuhan, China. Established in 2008, the company operates in the healthcare, software and internet services, and medical equipment manufacturing industries. With a team of 501-1,000 employees, Wuhan Easy Diagnosis Biomedicine Co., Ltd. is a leading manufacturer of in vitro diagnostic reagents and diagnostic equipment. Their product portfolio includes molecular diagnostic products, immunodiagnostic products, and blood gas diagnosis products. Located in the National Biological Industry Base in Wuhan province, China, the company is involved in research and development, production, and sales of their products both domestically and internationally. Wuhan Easy Diagnosis Biomedicine Co., Ltd. offers comprehensive solutions for various medical departments, including cardiovascular disease, kidney disease, infectious disease, endocrine and metabolic diseases, obstetrics and gynecology, and eugenics. Their goal is to become the leading enterprise in the high science and technology field of point-of-care testing (POCT) and to provide rapid and accurate diagnostic solutions. The company is committed to promoting the use of POCT throughout the world to improve human health. Wuhan Easy Diagnosis Biomedicine Co., Ltd. is also the first company in China to develop bedside, rapid, and quantitative detection in whole blood. Their products have obtained ISO13485:2016 and CE certifications, and more than 20 parameters of their POCT rapid diagnostic products are registered with the SFDA.